Piergiorgio Giannessi

Concomitant versus sequential administration of epirubicin and paclitaxel as first‐line therapy in metastatic breast carcinoma

PierFranco Conte, Valentina Guarneri, Paolo Bruzzi et al. · Cancer · 2004 · 69 citations · Full text

Medicine, Oncology, Pharmacology +13

Accelerated versus standard cyclophosphamide, epirubicin and5-fluorouracil or cyclophosphamide, methotrexate and5-fluorouracil: a randomized phase III trial in locally advanced breast cancer

Editta Baldini, G. Gardin, Piergiorgio Giannessi et al. · Annals of Oncology · 2003 · 69 citations · Full text

Medicine, Oncology, Pharmacology +13

Primary chemotherapy in locally advanced breast cancer (LABC): effects on tumour proliferative activity, bcl-2 expression and the relationship between tumour regression and biological markers

Paola Collecchi, Editta Baldini, Piergiorgio Giannessi et al. · European Journal of Cancer · 1998 · 44 citations

Medicine, Cancer Biology, Oncology +15

Multicenter randomized phase III trial of Epirubicin plus Paclitaxel vs Epirubicin followed by Paclitaxel in metastatic breast cancer patients: focus on cardiac safety

Editta Baldini, Tiziana Prochilo, B. Salvadori et al. · British Journal of Cancer · 2004 · 33 citations · Full text

Medicine, Oncology, Pharmacology +17

Relationship of variations in tumor cell kinetics induced by primary chemotherapy to tumor regression and prognosis in locally advanced breast cancer

G. Gardin, Angela Alama, R. Rosso et al. · Breast Cancer Research and Treatment · 1994 · 33 citations

Medicine, Cell Biology, Oncology +14